文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

弗莱明基金:中低收入国家抗菌药物耐药监测能力建设的设计与路径

The Fleming Fund: Key Features of Design and Approach to Strengthening Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries.
PubMed 文献 · Clin Infect Dis · 2026-01-01

文章描述其设计逻辑、治理与资助架构,并指出第二阶段从数据生成转向数据解读、传播与政策应用,为大规模监测系统强化提供经验。

要点

  • 弗莱明基金以One Health框架覆盖人类、动物与环境健康,支持25国AMR监测。
  • 资助重点包括实验室强化、人力建设、数据系统、质量保证与多部门协调。
  • 第二阶段转向数据解读、传播与政策实践使用,强调可持续国家监测职能。

核心结论

  • 弗莱明基金是大规模监测系统强化的案例,说明从外部支持的能力建设走向可持续国家监测职能需要时间、协调与制度嵌入。

研究设计与样本

  • 本文基于项目文件、评估证据与利益相关者观点,分析弗莱明基金的设计逻辑、治理安排、资助架构与战略重点演变。

主要发现

  • 基金通过One Health方法整合人类、动物与环境健康领域的监测能力建设。
  • 项目组合包括实验室强化、人力发展、数据系统、质量保证、采样路径与多部门协调。
  • 第二阶段从初期强调数据生成转向更关注数据解读、传播及在政策与实践中的使用。

临床怎么用

  • 可借鉴其多部门协调与实验室、人力、数据系统联动的综合干预思路。
  • 监测能力建设应重视数据解读、传播与政策应用,而非仅停留在数据生成。
  • 可持续的国家监测职能需要长期投入、制度嵌入与跨部门协作。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This paper examines the Fleming Fund as a major long-term investment in strengthening antimicrobial resistance (AMR) surveillance in low- and middle-income countries. Established by the UK Department of Health and Social Care in 2015, the Fund committed up to £498 million to support surveillance capacity across 25 countries in Africa and Asia through a One Health approach spanning human, animal and environmental health. The paper situates the Fleming Fund within wider global concern about AMR and highlights surveillance as essential for stewardship, policy and international coordination. It describes the Fleming Fund's design logic, governance arrangements, grant architecture and evolving strategic priorities, with particular attention to how the program combined laboratory strengthening, workforce development, data systems, quality assurance, sampling pathways and multisectoral coordination to generate credible and usable AMR data. The analysis also examines the Phase 2 shift from an initial emphasis on data generation toward greater attention to data interpretation, dissemination and use in policy and practice. Drawing on program documentation, evaluation evidence and stakeholder perspectives, the paper presents the Fleming Fund as an important case of large-scale surveillance system strengthening in resource-constrained settings. It argues that the Fund offers wider lessons on the time, coordination and institutional embedding required to move from externally supported capacity building toward sustainable national surveillance functions. These lessons are relevant to future AMR investments and to broader debates on global health security, health systems strengthening and One Health implementation.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Shorten T, Clarke J, Drake A, et al. The Fleming Fund: Key Features of Design and Approach to Strengthening Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries. Clin Infect Dis. 2026. PMID: 42895839. doi:10.1093/cid/ciag499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。